Tuesday, 04 Nov 2025

MedPulse360

Real-World Analysis Shows Growing Use of Octave’s MS Disease Activity Test in Clinical Practice
13 September, 2025

Importance of Patient Selection and Future Therapies in Alzheimer Treatment
13 September, 2025

This Week on NeurologyLive® — August 11, 2025
13 September, 2025

Alzheimer Psychosis Agent ACP-204 Shows No Impact on Corrected QT Intervals in Phase 1 Analysis
13 September, 2025

Maintaining Efficacy in Safer Donanemab Dosing Regimen
13 September, 2025

NeurologyLive® Brain Games: August 10, 2025
13 September, 2025

Discussing the Transition from Pediatric to Adult Epilepsy Care: Josiane Lajoie, MD
13 September, 2025

NeurologyLive® Friday 5 — August 8, 2025
13 September, 2025

Donanemab Dosing and ARIA Risk in TRAILBLAZER-ALZ 6
13 September, 2025

Elecsys Blood Test Gains EU Approval, FDA Expands Fremanezumab Indication Into Pediatrics, VX-993 Fails Phase 2 Pain Trial
13 September, 2025
📢

Advertisement

300x250 Banner

Recent Content

COPD Biologics: Early Treatment Insights

Pulmonology • 2 hours ago

Antihypertensive Medication Guidelines

Cardiology • 4 hours ago

Juvenile Arthritis Care Transition

Rheumatology • 6 hours ago